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Bacterial cellulose (BC) is a highly pure form of cellulose and possesses superior
physico-mechanical properties with wide range of applications. These properties of BC
can further be improved by various modifications, including its regeneration from the BC
solution. In the current research work, regenerated BC (R-BC) matrices were prepared
using N-methyl-morpholine-oxide (NMMO; 50% w/w solution in water) and loaded
with model drugs, i.e., famotidine or tizanidine. The characterization of drug loaded
regenerated BC (R-BC-drug) matrices was carried out using Fourier transform infrared
spectroscopy (FTIR), x-ray diffraction (XRD) analysis, scanning electron microscopy
(SEM) and thermogravimetric analysis (TGA), which revealed the stability of matrices
and successful drug loading. Results of dissolution studies showed immediate (i.e., >
90%) drug release in 30min. The drugs release data was found to best fit into first order
kinetics model having R2 values >0.99 for all the formulations. These results indicated
that regenerated BC-based matrices had the ability to be used for delivery of orally
administered drugs.
Keywords: bacterial cellulose, drug delivery, famotidine, tizanidine, regeneration
INTRODUCTION
Cellulose is the most abundant, inexpensive, biodegradable, and renewable biomaterial obtained
from cotton, wood, and other plant sources, which often contains pectin, lignin, and hemicellulose
as biogenic contaminations (Khan et al., 2015; Hickey and Pelling, 2019). In contrast, bacterial
cellulose (BC) is highly pure, non-cytotoxic and non-pyrogenic biomaterial, obtained by culturing
the colonies of selected bacterial species, particularly Gluconacetobacter xylinus (G. xylinus) (Ávila
et al., 2015; Ullah et al., 2016a). The features like molding ability into the desired shape, ultrafine,
and well-organized fibrous network, and ability of absorption and retention of water make BC
superior to plant based cellulose (Sajjad et al., 2020; Souza et al., 2020). BC finds applications
in the preparation of medical devices, tissue engineering and reconstructive surgery, and as
supportive scaffold for reconstruction of auricular cartilage (Ávila et al., 2015; Möller et al., 2017).
In addition, BC has been studied for potential applications, such as tissue proliferation, cell growth,
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treatment of wounds, mesenchymal cells differentiation, enzymes
and bioactive compounds delivery (Klinthoopthamrong et al.,
2020), and as-synthesized as well as surface modified matrices
(Badshah et al., 2017,18) and capsules shells for oral drug delivery
(Ullah et al., 2017).
To meet the current research demand and to explore
further potential applications of BC in various fields, several
physical and chemical procedures have been reported in the
literature for preparation of BC based nano-composites (Ullah
et al., 2016a,b) and bio-functionalized polymers (Badshah
et al., 2018). Out of these methods, the most popular are the
surface modification, and novel dissolution and regeneration
process (Khalid et al., 2017; Ullah et al., 2019). Limited
data is available regarding biomedical and pharmaceutical
applications of regenerated bacterial cellulose (R-BC). The
applications of R-BC include microfluidic column for protein
separation, electricity conducting multi-walled carbon nano-
tubes (Phisalaphong et al., 2008; Chen et al., 2016), novel
nano-porous membrane for filtration and diode for light
emission (Chen et al., 2009, 2016). In addition, R-BC has
been studied as wound dressing material for the delivery of
nanoparticles, as scaffold for tissue regeneration (Ul-Islam et al.,
2014), delivery of antibacterial agents and for biomedical tissue
engineering (Shafiei et al., 2014; Reddy and Yang, 2015). In
addition to above-mentioned applications, BC forms a single
excipient based intact oral dosage form due its higher tensile
strength in comparison to the existing conventional solid
dosage forms. Moreover, the as-synthesized BC membrane has
limited thickness and more time is required to obtain desired
thickness. In case of regenerated BC, the matrices with desired
thickness can be easily produced by increasing the quantity
or concentration of BC solution (Badshah et al., 2017, p.
18; Ullah et al., 2017). Similarly, R-BC is more amorphous
and easily biodegrade in comparison to as-synthesized BC
and thus have high potential for drug delivery to the body
parts, wherein degradation of BC is desired (Ullah et al.,
2019).
The process of BC regeneration is associated with certain
shortcomings, such as its limited solubility in solvents
(commonly used for plant cellulose) and inability to tailor
the polymeric properties after regeneration (Reddy and Yang,
2015). The literature studies showed that N-methyl-morpholine-
oxide (NMMO) is an environment friendly and recyclable
solvent (Shafiei et al., 2014; Reddy and Yang, 2015), and possesses
better cellulose dissolution properties as compared to other
chemicals (El-Wakil and Hassan, 2008; Xu et al., 2015). The use
of NMMO revolutionized the regeneration process of cellulose,
and expanded its applications from textiles and cotton fiber
spinning industry (Xu et al., 2015) to biomedical field (Isogai
and Atalla, 1998; Zhu et al., 2006). Literature revealed the
availability of several studies on the dissolution and regeneration
of plant based cellulose, but little data is available related to
BC regeneration. In addition, no studies have been reported
regarding R-BC applications as matrices for oral delivery of
drugs. Therefore, the current research was designed to dissolve
and regenerate BC for drug delivery using NMMO as solvent.
In the current research work, R-BC-drug (famotidine and
tizanidine) matrices were prepared for the first time using
NMMO as solvent. The matrices were characterized using FTIR,
XRD, SEM and TGA. The matrices were evaluated (in-vitro)
using simulated gastric conditions with objective to explore the
possible applications of R-BC in oral drug delivery.
MATERIALS AND METHODS
Materials
Anhydrous D-glucose (Dae-Jung, Gyeonggi-do, Korea), agar
and peptone (Oxide, Hants, UK), sodiumhydroxide (Sigma
Aldrich, St. Louis, USA), citric acid monohydrate (RDH,
Seelze, Germany), sodium dihydrogen phosphate and yeast
extract (Merk, Darmstadt, Germany), NMMO 50% (w/w)
aqueous solution (a kind gift from Amines and Plasticizer,
Mumbai, India), tizanidine HCl (JPN Pharma, Mumbai,
India), famotidine (Suleshvari Pharma, Gujarat, India), and
hydrochloric acid (Fishers Chemicals Ltd, Loughborough, UK)




Hestrin Schramm (HS) liquid medium, containing glucose
anhydrous 2% citric acid monohydrate 0.11%, yeast extract 0.5%,
peptone 0.5%, NaH2PO4 0.27% and distilled-water, was prepared
(pH 6.0) and sterilized (121◦C for 20min). For the preparation
of the pre-culture, the colonies of G. xylinus were added into
HS medium (50mL) in conical flask (100mL) and incubated
for 24 h at 30◦C and 150 rpm in shaking orbital incubator (J.P.
Selecta S.A, Spain). Then, 20mL of the pre-cultured medium was
added into basal HS medium in a rectangular container (6 cm ×
24 cm× 18 cm) and kept in static incubator (Memmert, 100–800,
Germany) at 28◦C for 7 to 15 days. The prepared BC sheets was
thoroughly washed using distilled water followed by addition of
0.3M sodium hydroxide and sterilized at 121◦C for 20min, to
remove culture medium remnants and bacterial colonies. Then,
distilled water was used for complete washing of BC till the pH
became neutral and stored in distilled water at 4◦C for further
use (Badshah et al., 2017; Ullah et al., 2017).









(%) (n = 3)
F1 1 : 0.25 3.50 0 22.97 ± 0.81
F2 1 : 0.50 3.25 0 24.62 ± 3.98
F3 1 : 0.75 3.20 0 27.70 ± 3.24
G1 1 : 0.085 2.50 0 17.65 ± 1.80
G2 1 : 0.17 2.45 0 24.79 ± 3.27
G3 1 : 0.25 2.65 0 28.32 ± 1.00
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Preparation of Regenerated Bacterial Cellulose Drug
Matrices
BC was dried at 60◦C for 10 h in a heating oven (SANFA, DHG-
9202, Jiangsu Jinyi, China), followed by grinding to convert
it into powder form. Then, powdered BC (2 g) was gradually
added to NMMO solution (50 g) in glass petri plates (90mm
× 10mm) and heated at 70◦C for 24 h to dissolve it. The BC
solution was added with different concentrations of famotidine
and tizanidine (Table 1) and thoroughly stirred until dispersed
uniformly. The BC-drug mixtures were allowed to stand at
room temperature (25◦C) until solidification (6 h). In order
to remove NMMO, the R-BC-drug sheets were incubated in
50mL distilled water for 96 h with regular replacement of fresh
washing medium each 24 h (4 times) and finally freeze-dried
(FreeZone 6, catalog No. 7752030, LABCONCO, USA) at−33◦C
and 0.025 mbar (Ul-Islam et al., 2014; Khan et al., 2015).
Round shaped matrices were prepared from the R-BC-drug
sheets using a specially designed fabricator with 12mm diameter.




The samples were dried at 50◦C for 24 h prior to measurement.
FTIR spectra for R-BC, drugs and R-BC-drug matrices was
recorded using FTIR spectrophotometer (Perkin-Elmer Frontier
FTIR Spectrometer, USA) in the spectral range of 4,000–400
cm−1 at resolution rate of 4 cm−1, with an ATR Pike Gladi ATR
diamond crystal.
X-Ray Diffraction Analysis
XRD measurements were employed by means of x-ray
diffractometer (D8 ADVANCE, BRUKER, Co. USA) with
radiation Cu Kα at 2.29 Å and operated at room temperature for
the determination of crystallinity of R-BC, drugs and R-BC-drug
matrices. The sample scanning speed was 6◦/min and the angle
for scanning (2θ) used was in the range of 10–60◦.
Field Emission Scanning Electron Microscopy
The surface morphology analysis of R-BC and R-BC-drug
matrices was carried out with field emission scanning electron
microscopy (LEO Ultra 55, LEO Electron Microscopy Ltd,
Cambridge, UK). The samples for cross section analysis were
prepared under the liquid nitrogen conditions. All the samples
were fixed on the SEM holder using adhesive tape prior to
proceeding for analysis. The samples were exposed for 1min
for sputter coating with gold in an atmosphere provided with
Argon (S150B Sputter Coater, Edwards, England) to determine
the surface topography and morphology.
Thermogravimetric Analysis
Thermal stability analysis of the R-BC-drug matrices was carried
out with the help of thermogravimetric analyzer (TGA/DSC 3+,
Mettler Toledo, UK). Thermogram of samples was attained in the
temperature range of 35 to 800◦Cwith an increment of 10◦C/min
under the nitrogen atmospheric conditions.
Thickness and Drug Loading Efficiency (%)
The R-BC-drug matrices thickness was measured using a Vernier
caliper (SparkFun, USA). Percent drug loading of the matrices
were calculated by averaging the amount of drug released of all
FIGURE 1 | Schematic diagram showing the general process of BC regeneration, drug loading, and matrices preparation.
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the formulations during dissolution. The following equation was
used to calculate matrices percent drug loading.
Drug laoding efficiency (%)
=
Loaded drug (based on the released amount)
Amount of drug feed initially
× 100
Friability Test
Friability test of the matrices was performed using a Friability
Tester (FT-L, Galvano Scientific, Pakistan) having speed of
25 rpm and time limit of 4min (Badshah et al., 2017). The






WhereW1 represents pre-test weight ofmatrices,W2 denotes the
weight of matrices after test and x show the percent weight loss.
In-vitro Drug Release
The release of drugs from the R-BC-drugmatrices was performed
in simulated gastric conditions, i.e., 0.1N HCl solution (900mL)
maintained at 37± 0.5◦C using USP type-I dissolution apparatus
(Dissolutest, Prolabo, France). The paddle rotation speed was
in tune of 50 rpm. Samples (5mL) from the medium were
withdrawn at designated time intervals and replaced with an
equal amount of fresh medium. The amount of drug released was
tested using UV-spectrophotometer (Cary 60 UV-Vis, Agilent
Technologies, USA) at 265 nm and 320 nm for famotidine and
tizanidine, respectively. All the drug release experiments were
performed in triplicate. The data obtained was averaged and
presented as cumulative percent release vs. time (Badshah et al.,
2017, 2018).
Drug Release Kinetics
The mechanism for drug release from R-BC-drug matrices was
studied by applying selected kinetics models including
Zero order(Qt = Q0 + K0t),
Where “Qt” is the cumulative amount of drug release at time “t”
“Q0” is the initial amount of drug at time “0,” “K0” is zero order
rate constant and “t” is the time.
First order(Log Qt = Log Q0 + Kt/2.303),
Where “Qt” is the cumulative amount of drug release at time “t”
“Q0” is the initial amount of drug at time “0,” “Kt” is first order
rate constant and “t” is the time.
Higuchi(Qt = KH t
1/2)
Where “Qt” is the cumulative amount of drug release at time “t”




Whereas “Qt” is drug cumulative amount released at time “t,”
“Q” is the total amount of drug in the dosage form, “Kkp”
is Korsmeyer-Peppas rate constant, “t” is the time and “n” is
diffusion or release exponent (Gouda et al., 2017; Ullah et al.,
2017).
Statistical Analysis
The results obtained from three independent replicate
experiments were presented as mean ± SD. The results
were analyzed using GraphPad Prism 5.0 software (GraphPad
Software Inc. USA). The statistical analysis was performed
using one way ANOVA with post-hoc Tukey’s test, keeping the
level of significance with probabilities of ∗p < 0.05, ∗∗p < 0.01,
and ∗∗∗p < 0.001.
RESULTS AND DISCUSSION
Preparation of R-BC-Drug Matrices
In the current study, BC was successfully dissolved in NMMO,
incorporated with model drugs in various concentrations and
finally regenerated. Several solvents can dissolve BC, however,
NMMO was selected in the current study because it is recyclable
and environment friendly solvent (Gao et al., 2011; Shafiei
et al., 2014). The BC dissolution and regeneration require
high temperature and longer duration, which have strong
impact on the BC intra- and intermolecular hydrogen bonds
breaking, crystallinity, surface morphology, thermal stability
and mechanical properties (Gao et al., 2011; Xu et al., 2015).
Moreover, the R-BC-drug matrices were subjected to various
characterization techniques to study the effects of temperature
and chemical changes (if any) during this process (Gao et al., 2011
Ul-Islam et al., 2014).
Physical Evaluation of R-BC-Drug Matrices
The prepared matrices were subjected to various physical tests.
The matrices thickness was observed to be directly proportional
to the initial concentration of drug for loading (Table 1). The data
of friability test showed no weight loss during the test (Chen et al.,
2009; Badshah et al., 2017). Similarly, the amount of drug loaded
into R-BCwas directly proportional to the initial concentration of
the drug added to BC solution before the regeneration (Table 1).
In case of tizanidine, the drug loading efficiency was directly
proportional to the amount of drug used in the loading process.
However, in case of famotidine, the drug loading efficiency was
almost constant irrespective of the amount of drug used in the
loading process. The possible reason for this constant loading
might be that a fixed quantity of BC is available for absorption
of drug (Sharma et al., 2016) and the drug concentrations beyond
the maximum saturation capacity of the BC cannot be absorbed.
Characterization of R-BC-Drug Matrices
Fourier-Transform Infrared Analysis
FTIR technique was used to study the compatibility and
structural changes of the formulations ingredients, i.e., R-BC
and drug loaded R-BC. FTIR spectra for BC, R-BC, famotidine,
R-BC-famotidine, tizanidine and R-BC-tizanidine have been
shown in Figure 2. The spectrum of as-synthesized BC showed
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FIGURE 2 | FTIR spectrum of the prepared BC, R-BC, famotidine,
R-BC-famotidine, tizanidine, and R-BC-tizanidine matrices for comparison.
characteristic band at 3,500–3,200 cm−1 and at 1,160 and 1,068
cm−1, which are assigned to OH stretching, OH wagging and
C-O-C pyranose ring (Chen et al., 2009; Badshah et al., 2017).
The spectrum of R-BC has broad peaks at 3,500–3,200 cm−1,
representing OH stretching due to breakage of inter and intra
molecular hydrogen bonding. In addition, the appearance of
peaks in as-synthesized and regenerated BC at 1,160 and 1,068
cm−1 represent the C-H scissor vibration (Gao et al., 2011; Shafiei
et al., 2014). The IR spectra of R-BC-famotidine revealed a broad
band between 3,500 and 3,200 cm−1, which may arise due to
the merger of –OH and NH2 groups of R-BC and famotidine,
respectively. Similarly, the region of 2,850–2,950 cm−1 represents
the C–H bending of R-BC vibration (Sagdinc and Bayari, 2005;
Arima and Iwata, 2007). The band at 1,553 cm−1 represent NH2
group, while at 1,290 and 1,135 cm−1 revealed CH2=S and SO2
groups of famotidine, respectively (Sagdinc and Bayari, 2005;
Cheng and Lin, 2008). The peaks at 1,078 and 990 cm−1 represent
bending vibration due to NH2 group of famotidine and CH2
group of R-BC (Sagdinc and Bayari, 2005; Souza et al., 2020). The
band at 895 cm−1 represent glycosidic linkage of R-BC and 850
cm−1 has been assigned to the CH2 skeleton of famotidine and
R-BC (Sagdinc and Bayari, 2005; Gao et al., 2011).
The IR spectrum of R-BC-tizanidine IR displayed bands at
3,200–3,500 cm−1 that represent OH and NH2 groups of R-BC
and tizanidine, respectively. Similarly, bands at 1,665 cm−1
indicates the C=C aromatic stretching of tizanidine (Aamir
and Ahmad, 2010; Badshah et al., 2018). The peaks at 1,450–
1,200 cm−1 indicates R-BC C–H stretching vibration. The C–
N stretching was confirmed by peak at 1,290 and 1,187 cm−1,
while bands at 1,113 and 1,068 cm−1 confirm the C–Cl group of
tizanidine (Aamir and Ahmad, 2010; Badshah et al., 2017, 2018).
The presence of characteristic absorption bands of respective
drug functional groups with slight shift shows drug incorporation
into the R-BC. There has been no new peak appearance in
FIGURE 3 | XRD pattern of R-BC, famotidine, R-BC-famotidine, tizanidine,
and R-BC-tizanidine.
the FTIR spectrum of the respective R-BC-drug composites,
which show absence of any chemical boding formation between
the components.
X-Ray Diffraction Analysis
Change in the crystallinity of the R-BC and drug loaded
matrices was evaluated using XRD technique. XRD patterns of
BC, R-BC, famotidine, R-BC-famotidine, tizanidine HCl and
R-BC-tizanidine HCl have been displayed in Figure 3. BC has
appearance of characteristic peaks at 14.5, 16.5, and 22.5◦. R-BC
showed comparative peak broadening at 19.8 and 22.7◦, which
confirmed the conversion of BC to amorphous form as a result of
inter and intra molecular hydrogen bonding disruption during
the dissolution process (Lee et al., 2014; Badshah et al., 2017).
The pattern for famotidine displayed crystalline nature and the
R-BC-famotidine showed few and shorter peaks, which indicated
lower crystalline nature and amount of drug loaded. The peaks
at 15, 22, 25.6, 30, and 35.5◦ also showed the presence of
famotidine in crystalline form (Razavi et al., 2014). In case of
R-BC-tizanidine, distinct peaks at 16, 18.7, and at 32.55, 37.55,
and 41.5◦ with reduced intensity confirmed the presence of
tizanidine in crystalline form (Aamir and Ahmad, 2010; Badshah
et al., 2017). The presence of the respective drug specified peaks
confirmed the effective loadings of drugs into the R-BC-drug
matrices in crystalline form. The nanoporous BC can convert the
drug into amorphous form when loaded into the pores (Ullah
et al., 2019), however, the drug is also present in crystalline form
on the surface of matrices due to excessive loading, which is
further confirmed by the SEM analysis as shown in Figure 4.
Scanning Electron Microscopy
Surface morphology of R-BC and the matrices with loaded
drugs was studied using SEM. The SEM micrographs of
surface and cross section of R-BC and R-BC-drugs matrices
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FIGURE 4 | SEM images of (A) R-BC, (B) R-BC-famotidine, and (C) R-BC-tizanidine matrices.
were obtained at varying magnifications. Figure 4 shows
the typical microphotographs for R-BC, R-BC-famotidine
and R-BC-tizanidine. The cross-section for R-BC (Figure 4A)
showed porous layers of different dimensions. These pores
may be attributed to the water crystallization during R-BC
regeneration process (El-Wakil and Hassan, 2008; Xu et al.,
2015). The cross sectional micrograph for the R-BC did not
show formation of fibrous structure, which is the confirmation
of the native BC fiber network destruction/annihilation during
the regeneration process. Similarly, the surface morphology of
the R-BC also showed smooth appearance and absence of fibrous
network, which confirmed the dissolution of BC followed by
regeneration (Wan et al., 2006; Ul-Islam et al., 2014). The cross
sectional images of the R-BC famotidine (Figure 4B) and R-
BC-tizanidine (Figure 4C) showed comparatively less porous
structure than pure R-BC. The possible reason may be that the
loaded drugs have filled most of the spaces produced. In addition
to this, the probable reason of pores formation may be the wash
out of some of the loaded drug during the solvent exchange of
NMMO with deionized water and the forced migration of the
loaded drug content to the surfaces during the freeze drying of the
matrices. The micrographs revealed the presence of drug crystals
on the surface of the R-BC film, which confirms successful
drug loading.
Thermogravimetric Analysis
In order to study the thermal stability of R-BC and drugs
loaded matrices, thermal analysis was carried out. Thermogram
of BC, R-BC, and R-BC-drugs matrices were obtained in order
to study the thermal behavior of these samples (Figure 5). In
the initial phase of degradation, BC showed 5% weight loss
at temperature up to 280◦C possibly due to evaporation of
adsorbed water. In the second phase, there is a sharp decline
in weight (70%) at a temperature between 280 and 380◦C due
to breakdown of glycosidic linkages. The rest of the content
(25%) remained as ash till 800◦C. These results are in agreement
with the previous studies (Chen et al., 2016). Similarly, the R-
BC displayed 5% weight loss up to 220◦C followed by a sudden
decline (70%) due to depolymerization and breaking down of
glycosidic backbone in the temperature range of 220–380◦C.
The remaining portion (25%) existed as ash till 800◦C. These
results were also consistent with the reported thermal studies
for regenerated BC (El-Wakil and Hassan, 2008; Gao et al.,
2011). On the other hand, R-BC-famotidine and R-BC-tizanidine
displayed 6 and 8% loss in weight up to 100◦C, respectively.
This weight loss may be due to evaporation of surface adsorbed
water molecules in R-BC-drug matrices (Badshah et al., 2017).
With the rise in temperature from 100 to 200◦C, the weight
loss count for both drugs of matrices was 80% and the
possible reason may be the elimination of hydroxyl groups and
combustion of the organic part of R-BC. In addition, the melting
temperature of the loaded drug might have caused the abrupt
weight loss (El-Wakil and Hassan, 2008; Gao et al., 2011). The
data showed that R-BC-famotidine and R-BC tizanidine was
maximally degraded (marked as ash) till 800◦C (Badshah et al.,
2017).
In-vitro Drug Release Studies
The release of drugs from the R-BC-drug matrices was studied in
simulated gastric fluid, i.e., 0.1N HCl solution using USP type-I
dissolution apparatus under predefined conditions. Figure 6
and Figure 7 show the in-vitro drug release profile from
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FIGURE 5 | Curves of the thermogravimetric analysis for the prepared
matrices of R-BC, R-BC-famotidine, and R-BC-tizanidine.
FIGURE 6 | In-vitro drug release profile of R-BC-famotidine (F1–F3) and
R-BC-tizanidine (G1–G3) matrices using USP type-I dissolution apparatus.
R-BC-famotidine matrices (F1–F3) and tizanidine loaded R-BC
matrices (G1–G3). The matrices F1, F2, and F3 released 78.03
± 3.77, 70.52 ± 6.52, and 73.04 ± 2.85% of the drug content,
respectively, in the initial 15min (p < 0.001) (Figure 7). The
formulation F1 released higher concentration of drug than F2
and F3, whereas, no significant difference was observed between
F2 and F3. Similarly, 93.57 ± 2.36, 92.28 ± 5.30, and 93.40 ±
3.00% of the drug was released has been shown by F1, F2, and
F3 matrices after 30min, which is not significant. However, at
later time point i.e., 45min, it was observed that regardless of
the concentrations of loaded drug (Table 1), thematrices released
most of the drug content (>95%), which was observed as 98.25
± 0.78, 97.34 ± 2.99, and 98.58 ± 1.36% for F1, F2, and F3,
respectively. In contrast to famotidine loaded matrices, the drug
release from the R-BC-tizanidine matrices, i.e., G1, G2, and G3
was 76.260 ± 5.20, 63.40 ± 7.74, and 65.43 ± 7.73% at 15min,
respectively. These results reveals significant difference in drug
release (p < 0.05) between formulations G1 with G2 and G3,
whereas G2 and G3 have no significant difference. Moreover,
98.30 ± 0.4, 86.98 ± 5.59, and 91.33 ± 4.93% of the drug
was released (p < 0.05), respectively, after 30min from these
matrices. This shows that G1 has released higher concentrations
of the loaded drug as compared to G2 and G3. This behavior of
comparatively slow drug release from G2 and G3 might be due
to the higher concentrations of the drug (remained intact with
R-BC) into matrices (Table 1). The R-BC-tizanidine matrices
released most of the drug (>95%) after 45min of studies and was
found to be 99.91 ± 0.15, 95.65 ± 2.21, and 99.36 ± 0.72% for
the formulations G1, G2, and G3 (p < 0.01), respectively. It was
observed that t90% (time in which 90% of the drug was released)
is <1 h for both of the drug loaded matrices. The comparison
of drug release from F1–F3 and G1–G3 show that famotidine
loaded matrices have released higher concentrations of drug as
compared to tizanidine in the initial 15min. This might become
possible due to larger exposed surface of R-BC for binding of
the lower concentration of tizanidine as compared to famotidine
loaded formulations (Kolakovic et al., 2013). However, after
30min there have been no significant changes observed in drug
release between F1–F3 and G1–G3. The possible reasons for the
faster release of drugs from all formulations may be the aqueous
solubility of the drugs (Badshah et al., 2017) and breakdown
of the interconnected fibrous network hydrogen bonding of the
BC as result of dissolution (Lee et al., 2014; Xu et al., 2015). R-
BC has higher hydrophilic nature and absorbs aqueous solution
faster. This feature might have facilitated the rapid penetration
of dissolution medium into matrices, which resulted in faster
dissolution and release of drugs (Gao et al., 2011; Badshah
et al., 2017). In addition, the presence of loaded drug particles
might have effected the film and pores formation (Figure 4)
during the regeneration process, which have made the system
strongly hydrophilic and thus facilitateed the rapid diffusion of
dissolutionmedium into the matrices. These factors may resulted
in the faster drug release from the matrices (Fink et al., 2001).
Furthermore, the matrices washing for the removal of NMMO
and freeze-drying may have facilitated the drugmigration toward
the surfaces, which has resulted in faster dissolution of the
drugs and speedy release. This behavior might have facilitated
the desired concentrations of the drugs to be released in the
dissolution medium effectively (Isogai and Atalla, 1998; Ávila
et al., 2015). It was also observed that early drug release behavior
of R-BC have the potential for designing immediate release
formulations (i.e., in stomach) based on single polymer. As
mentioned above, the drug release is limited to few hours;
however, the drug release could further be tailored by using
other strategies with altered drugs aqueous solubility and their
interactions with the BC nanofibers (Kolakovic et al., 2012). For
statistical calculations of the effect of BC regeneration on the drug
release from the mentioned formulations (F1–F3 and G1–G3),
drug release results from as-synthesized BCmatrices (F0 and G0)
were used as reference (Figure 7).
It is evident from our current and previous studies that in
comparison to the existing conventional dosage forms, BC forms
a single excipient based intact oral dosage form due its higher
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FIGURE 7 | Comparison of R-BC matrices drug release data at various intervals of time i.e., (A) represent R-BC-famotidine matrices (F1–F3), at 0.25 and 0.5 h,
whereas (B) denote R-BC-tizanidine matrices (G1–G3) at 0.25, 0.5, and 0.75 h, using one way ANOVA with post-hoc Tukey’s test, keeping the level of significance
with probabilities of *p < 0.05, **p < 0.01, and ***p < 0.001. Data is presented as mean ± SD (n =3).
TABLE 2 | Drug release kinetics of famotidine and tizanidine from the R-BC-drug matrices.





F1 0.4896 72.276 0.9993 5.936 0.5722 91.901 0.101 0.9879
F2 0.3376 71.847 0.9997 4.935 0.6440 91.047 0.136 0.9771
F3 0.3753 72.206 0.9998 5.298 0.6208 91.750 0.122 0.9790
G1 0.5115 72.526 0.9980 6.025 0.5404 92.520 0.098 0.9757
G2 0.1349 71.326 0.9998 4.064 0.7337 89.766 0.182 0.9717
G3 0.2580 71.947 0.9978 4.510 0.6758 90.967 0.158 0.9626
tensile strength. Moreover, the as-synthesized BC membrane has
limited thickness and more time is required to obtain desired
thickness (Badshah et al., 2017; Ullah et al., 2017). In case of
R-BC, the matrices with desired thickness can be easily produced
by increasing the concentration of BC solution. Similarly, R-BC
is more amorphous and easily biodegraded compared to as-
synthesized BC and thus have high potential for drug delivery to
the body parts, wherein degradation of BC is desired (Ullah et al.,
2019).
Drug Release Kinetics From the
R-BC-Drug Matrices
The drug release kinetics studies revealed that the release of
drugs from the R-BC-drug matrices was dependent on the drug
concentration. The hydrophilic property of R-BC might facilitate
the diffusion of the medium into the matrices. It was observed
that drug release during dissolutions was best fitted into the first
order kinetics model with R2 value more than 0.99. The release
exponent “n” value of Korsmeyer-Pappas model was different
for in-vitro dissolution. In case of the dissolution studies, the
value of “n” was <0.5, which showed that release mechanism
was following Fickian diffusion (Badshah et al., 2017, 2018) as
presented in Table 2.
CONCLUSION
The current research work was carried out for the first time
to evaluate the potential applications of regenerated BC for
drug delivery. The R-BC-drug matrices were prepared using
NMMO as solvent. Characterization data showed that R-BC-
drug matrices were chemically and thermally stable. The drug
loading and in-vitro drug release studies revealed that R-BC-
drug matrices released more than 90% of the loaded amount
of drugs in the initial 30min during dissolution studies, which
followed the criteria for immediate release drug delivery system.
It can be concluded that R-BC, a novel and physically modified
form of BC, has the ability for designing matrices for the
delivery of drugs via oral route. However, further research
work is required for the exploration of its potential applications
in drug delivery via other routes of administration using
other drugs.
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